Gregory Sargen is Director of Avid Bioservices, Inc.. Currently has a direct ownership of 36,368 shares of CDMO, which is worth approximately $446,599. The most recent transaction as insider was on Dec 14, 2024, when has been sold 26,756 shares (Common Stock, $0.001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.4K
278.36% 3M change
278.36% 12M change
Total Value Held $446,599

GREGORY SARGEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2024
BUY
Exercise of conversion of derivative security
-
26,756 Added 42.39%
36,368 Common Stock, $0.001 p...
Dec 14 2023
BUY
Exercise of conversion of derivative security
-
9,612 Added 50.0%
9,612 Common Stock, $0.001 p...
Apr 11 2023
SELL
Open market or private sale
$141,902 $20.24 p/Share
7,011 Reduced 100.0%
0 Common Stock, $0.001 p...
Dec 14 2022
BUY
Exercise of conversion of derivative security
-
4,632 Added 39.78%
7,011 Common Stock, $0.001 p...
Dec 14 2021
BUY
Exercise of conversion of derivative security
-
2,379 Added 50.0%
2,379 Common Stock, $0.001 p...

Also insider at

TARA
Protara Therapeutics, Inc. Healthcare
GS

Gregory Sargen

Director
Tustin, CA

Track Institutional and Insider Activities on CDMO

Follow Avid Bioservices, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDMO shares.

Notify only if

Insider Trading

Get notified when an Avid Bioservices, Inc. insider buys or sells CDMO shares.

Notify only if

News

Receive news related to Avid Bioservices, Inc.

Track Activities on CDMO